
Case Study:
Acquisition and Integration
of Established Consumer
Healthcare Brands
Challange
A leading manufacturer of high-quality pharmaceuticals sought support for the acquisition and integration of 816 established consumer healthcare brands.
The initiative encompassed 250+ SKUs, 51 markets, and over 20 suppliers, with the goal of ensuring a seamless acquisition process and achieving day-one distribution in priority markets.
Our Approach
Commissioned to partner with the Post-merger Integration team to build and execute a lean PMO to drive efficiency and manage the complexities of this large-scale acquisition. We focused on:
Comprehensive RAIDD Framework Development: Leverage initial due diligence outputs to create a RAIDD (Risks, Assumptions, Issues, Dependencies, Decisions) framework, enabling proactive identification of risks and opportunities. This approach went beyond traditional risk tracking, embedding risk management into the broader portfolio, leading to additional commercial value and new opportunities.
Integrated Risk Management: Expanded the risk management process to be a central component of the PMO, embedding it across multiple functions and governance boards, which made risk management a key factor in portfolio reviews and strategic decision-making.
Extensive Coordination and Governance: Managed core program reporting and coordination across functions including, M&A, legal, trademarks, supply chain, commercial regulatory, quality, finance, and tax. This involved leading buyer/seller project update reviews and cross-functional calls, with 20-50 participants per meeting, ensuring comprehensive integration efforts.
Post-Deal Operational Oversight: Focused on 51 markets across regions from Latin America to Australia/New Zealand, enhancing integration, activities to ensure a smooth post-deal transition.
Process Optimization and Opportunity Creation: Implemented efficiencies in master data management, commercial analysis, and process improvements, contributing to value creation throughout the integration.
Results
The lean PMO program delivered significant outcomes, including:
On-time deal completion and day-one distribution readiness for priority markets
Streamlined legal and operational processes, which improved integration efficiency
Successful mitigation of multi-million dollar risks, ensuring a smooth transition
C-Suite support for footprint expansion, driven by the program’s success in managing a complex, multi-market acquisition.
Strategic Value Creation: Transformed risk management into a proactive, strategic driver that unlocked new opportunities and supported long-term growth.
This approach not only secured the successful acquisition of the 16 CHC brands but also established a strong foundation for sustainable growth and operational excellence.
Read More Case Studies
Scaling up drug substance production for Covid 19 vacine
Transforming Global Facilities Management for a leading Pharmaceutical Company